Literature DB >> 20476915

The role of the complement system in CNS inflammatory diseases.

Philip F Stahel1, Scott R Barnum.   

Abstract

Complement is an important component of both the innate and adaptive immune response that contributes to host defense in a variety of mechanisms, including inflammation, phagocytosis and cell lysis. Complement proteins are produced by all cell types in the CNS, and the same effector functions that protect the host from pathogens can mediate inflammation and tissue destruction in CNS diseases, leading to neurological deficits or even death. In the last 10 years, the development of complement inhibitors and a variety of animal models for CNS diseases has revealed that targeted inhibition of complement offers significant therapeutic potential. This review discusses the subtleties of targeted complement inhibition in CNS disease as an emerging therapeutic strategy.

Entities:  

Year:  2006        PMID: 20476915     DOI: 10.1586/1744666X.2.3.445

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  20 in total

1.  Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".

Authors:  Philip F Stahel; Michael A Flierl
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

Review 2.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

3.  Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease.

Authors:  Alexander J Szalai; Xianzhen Hu; Jillian E Adams; Scott R Barnum
Journal:  Mol Immunol       Date:  2007-03-13       Impact factor: 4.407

4.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

5.  Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Authors:  Theresa N Ramos; Anastasia A Arynchyna; Tessa E Blackburn; Scott R Barnum; James M Johnston
Journal:  JCI Insight       Date:  2016-07-07

Review 6.  The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.

Authors:  Jessy John Alexander; Aileen Judith Anderson; Scott Robert Barnum; Beth Stevens; Andrea Joan Tenner
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

7.  Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.

Authors:  Sebastian Weckbach; Miriam Neher; Justin T Losacco; Ashley L Bolden; Liudmila Kulik; Michael A Flierl; Scott E Bell; V Michael Holers; Philip F Stahel
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

Review 8.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

9.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

Review 10.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.